PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...
Delayed IPF diagnosis often results in significant lung function impairment, impacting patient outcomes and increasing hospitalization rates. Antifibrotic therapies, nintedanib and pirfenidone, are ...
Consultant respiratory physician Professor Peter George answers key questions on the diagnosis and management of pulmonary fibrosis and interstitial lung disease. Complete the module on Pulse 365 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results